Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ATN International | ATNI | Oct 17, 2024 | 33.48 | +1.76 |
Atomera | ATOM | Oct 17, 2024 | 3.39 | -6.35 |
Atossa Therapeutics | ATOS | Oct 17, 2024 | 1.45 | -1.36 |
Atour Lifestyle ADR | ATAT | Oct 17, 2024 | 26.03 | -3.38 |
ATRenew A ADR | RERE | Oct 17, 2024 | 2.51 | -4.56 |
AtriCure | ATRC | Oct 17, 2024 | 28.57 | -2.02 |
Atrion | ATRI | Oct 17, 2024 | 459.92 | 0.00 |
ATS Corporation | ATS | Oct 17, 2024 | 30.40 | -1.46 |
aTyr Pharma | ATYR | Oct 17, 2024 | 2.65 | -2.57 |
Auburn National Bank | AUBN | Oct 17, 2024 | 21.38 | +3.33 |
Auddia | AUUD | Oct 17, 2024 | 0.70 | +13.06 |
AudioCodes | AUDC | Oct 17, 2024 | 9.75 | +0.93 |
AudioEye | AEYE | Oct 17, 2024 | 24.26 | -5.12 |
Augmedix | AUGX | Oct 17, 2024 | 2.35 | 0.00 |
Ault Alliance | AULT | Oct 17, 2024 | 0.21 | 0.00 |
Ault Disruptive Technologies SPAC | ADRT | Oct 17, 2024 | 11.40 | 0.00 |
Auna S.A.A | AUNA | Oct 17, 2024 | 7.09 | +3.20 |
Aura Biosciences | AURA | Oct 17, 2024 | 10.29 | +0.39 |
Aura FAT Projects Acquisition A | AFAR | Oct 17, 2024 | 11.68 | 0.00 |
Aurinia Pharmaceuticals | AUPH | Oct 17, 2024 | 7.18 | 0.00 |
Aurora Cannabis | ACB | Oct 17, 2024 | 5.50 | -0.90 |
Aurora Innovation A | AUR | Oct 17, 2024 | 6.20 | -0.32 |
Aurora Mobile ADR | JG | Oct 17, 2024 | 5.95 | -1.98 |
Austin Gold | AUST | Oct 17, 2024 | 1.80 | +11.11 |
Australia Index MSCI Ishares | EWA | Oct 17, 2024 | 26.46 | 0.00 |
Australian Dollar Trust | FXA | Oct 17, 2024 | 66.30 | +0.45 |
Australian Oilseeds | COOT | Oct 17, 2024 | 0.75 | -0.23 |
Austria Investable Mkt Idx MSCI Ishares | EWO | Oct 17, 2024 | 22.01 | -0.78 |
authID | AUID | Oct 17, 2024 | 7.67 | -1.03 |
Autodesk | ADSK | Oct 17, 2024 | 290.57 | +0.48 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.